Venous thromboembolism in hospitalized patients with COVID-19: clinical and laboratory characteristics at…

Cohort studyJornal vascular brasileiro· 2026

Venous thromboembolism in hospitalized patients with COVID-19: clinical and laboratory characteristics at three tertiary care centers in a state capital in the Eastern Amazon.

Ester Almeida Carneiro Rodrigues da Silva, Adson Kevin Cunha Negidio, Tiago de Oliveira Vieira … Paulo Martins Toscano

Infectious DiseaseCohort studyQ3IF 0.8

Venous thromboembolism was confirmed in 1.30% of hospitalized COVID-19 patients.

Venous thromboembolism in hospitalized patients with COVID-19: clinical and laboratory characteristics at three tertiary care centers in a state capital in the Eastern Amazon.

Ester Almeida Carneiro Rodrigues da Silva … Paulo Martins Toscano

Jornal vascular brasileiro · 2026

Background

To date, the COVID-19 pandemic constitutes the greatest health care challenge of the century.

Purpose

This study describes the clinical and laboratory characteristics of hospitalized patients with venous thromboembolism confirmed during a COVID-19 infection.

Methods

This is an observational, longitudinal, and retrospective analytical study based on review of the medical records of patients admitted to three tertiary centers in the capital of Pará state, Brazil, with venous thromboembolism diagnosed by imaging.

1.30%

Results

1.30%

less than 2% of hospitalized patients developed a blood clot

More results

Mean age, C-reactive protein, D-dimer, body mass index, and length of hospital stay were 46.35 years, 143.23 mg/L, 4.12 µg/mL, 27.65 kg/m 2 , and 50.18 days, respectively.

No significant correlations (p < 0.05) were observed between presence of venous thromboembolism and any of variables studied.

“

Conclusion · 1 of 2

There appeared to be associations between some of the variables tested, but it was not possible to confirm any causal relationships.

Conclusion · 2 of 2

It is possible that epidemiological associations between COVID-19 and venous thromboembolism could be measured and better explained by possible confounding factors, such as simultaneous coinfections, preexisting health conditions, and others.

Venous thromboembolism in hospitalized patients with COVID-19: clinical and laboratory characteristics at three tertiary care centers in a state capital in the Eastern Amazon.

Venous thromboembolism in hospitalized patients with COVID-19: clinical and laboratory characteristics at three tertiary care centers in a state capital in the Eastern Amazon.

Related papers